MENU

BRIBF Stock BRII BIOSCIENCE (BRIBF, $0.23) was a top loser this quarter, falling -23.96%

A.I.dvisor
at Tickeron.com
Loading...
BRIBF - BRII BIOSCIENCE LTD
Tickeron

Loading...

Price: $0.2313
Daily change: -$0.0287 (-11.04%)
Daily volume: 5K
3-month price change: -$0.0729 (-23.96%)
Capitalization: $182.3M
Industry: Biotechnology
BRII BIOSCIENCE (BRIBF, $0.23) was a top loser over the last three months, falling -2 to $0.23 per share. A.I.dvisor analyzed 811 stocks in the Biotechnology Industry for the 3-month period ending July 25, 2025, and found that of them (6) exhibited an Uptrend while of them (3) demonstrated a Downtrend.

BRIBF in downward trend: price dove below 50-day moving average on July 25, 2025

BRIBF moved below its 50-day moving average on July 25, 2025 date and that indicates a change from an upward trend to a downward trend. In of 6 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BRIBF as a result. In of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BRIBF turned negative on July 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 14 similar instances when the indicator turned negative. In of the 14 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for BRIBF crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BRIBF's RSI Oscillator exited the oversold zone, of 4 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRIBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.468) is normal, around the industry mean (18.047). P/E Ratio (0.000) is within average values for comparable stocks, (58.309). BRIBF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.504). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (1111.111) is also within normal values, averaging (276.800).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRIBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
No. 1 North Yongtaizhuang Road
Phone
N/A
Employees
146
Web
https://www.briibio.com